Serial #79438530
LIVE

Serial Number

79438530

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79438530 Trademark

Serial Number: 79438530 • Registration: 8268687

Serial #79438530 is a trademark filed by Novartis AG on September 25, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

September 25, 2025

Registration Date

May 26, 2026

Published for Opposition

April 7, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2026 CNSA
REFUSAL PROCESSED BY IB
Feb 19, 2026 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2026 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 4, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 4, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 7, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 6, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 30, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 16, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 4, 2025 REPR